Pfizer Stock Today, November 26, 2025: Obesity Bet, Cancer Breakthrough and Legal Risks Shape PFE’s Outlook
Pfizer Inc. (NYSE: PFE) spent Wednesday trading slightly lower despite a stream of fresh headlines that cut both ways for sentiment. The stock hovered around $25.7, giving back a fraction of Tuesday’s nearly 2% gain, as investors weighed upbeat news on obesity drugs, cancer treatment and vaccines against ongoing legal and regulatory risks. MarketScreener+1 Below is a structured look at how Pfizer stock is trading today, and the key news from November 26, 2025 that’s shaping the story. PFE stock price today: small dip after a recent rebound Income‑focused investors continue to zero in on Pfizer’s dividend: From a valuation